Sector
PharmaceuticalsOpen
₹17.4Prev. Close
₹17.4Turnover(Lac.)
₹0Day's High
₹17.4Day's Low
₹17.452 Week's High
₹052 Week's Low
₹0Book Value
₹557.83Face Value
₹10Mkt Cap (₹ Cr.)
0.43P/E
0EPS
0Divi. Yield
016 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
24 May 2025
12:00 AM
AGM
Announcement Date: 24 May, 2025
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 0.25 | 0.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.42 | 14.38 | 11.35 | 12.8 |
Net Worth | 13.67 | 14.63 | 11.6 | 13.05 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 13.93 | 20.03 | 34.99 | 18.06 |
yoy growth (%) | -30.41 | -42.75 | 93.72 | -21.85 |
Raw materials | -12.61 | -13.61 | -28.77 | -15.17 |
As % of sales | 90.47 | 67.94 | 82.25 | 84.02 |
Employee costs | -0.66 | -0.82 | -0.73 | -0.67 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.58 | 4.55 | 3.56 | 0.8 |
Depreciation | -0.13 | -0.16 | -0.24 | -0.27 |
Tax paid | 0.13 | -1.14 | -1.01 | -0.23 |
Working capital | -2.91 | 4.93 | 2.21 | 7.24 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -30.41 | -42.75 | 93.72 | -21.85 |
Op profit growth | -110.42 | 18.2 | 284.62 | 3.38 |
EBIT growth | -109.87 | 20.91 | 354.74 | 22.72 |
Net profit growth | -113.13 | 33.18 | 343.57 | 68.61 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,682.05 | 94.39 | 4,03,580.14 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,783.05 | 81.52 | 1,80,068.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484.6 | 24.91 | 1,19,918.75 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,407.05 | 60.94 | 1,15,304.87 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,699.8 | 59.14 | 1,11,428.51 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Director & Chief Executive Off
Ramu S Deora
Non Executive Director
S S Sharma
Company Sec. & Compli. Officer
Ureca Shirish Shirole
Non Executive Director
Grace R. Deora
Independent Director
Shailendra Mishra
Independent Director
Vipul Desai
Sambhava Chambers,
4th Floor Sir P M Road,
Maharashtra - 400001
Tel: 91-22-22663150
Website: http://www.triochemproducts.com
Email: investor@triochemproducts.com
Unit No 1 Luthra Ind,
Andheri Kurla Road, Safed Pool Andheri(E,
Mumbai - 400 072
Tel: 91-22-2851 5606
Website: www.sharexindia.com
Email: sharexndia@vsnl.com
Summary
Triochem Products Ltd was incorporated in the year January 17, 1972. The Company is engaged in the business of manufacturer and exporter of pharmaceuticals products, API and chemicals.
Read More
Reports by Triochem Products Ltd
What is the Triochem Products Ltd share price today?
What is the Market Cap of Triochem Products Ltd?
What is the PE and PB ratio of Triochem Products Ltd?
What is the 52 Week High and Low of Triochem Products Ltd?
What is the CAGR of Triochem Products Ltd?
What is the shareholding pattern of Triochem Products Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.